BioLineRx (BLRX) Tops Q1 EPS by 13c

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital